Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuhiro Nako

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Tohoku Journal of Experimental Medicine|May 31, 2016
The Reduction in Urinary Glutamate Excretion Is Responsible for Lowering Urinary pH in Pink Urine SyndromeSusumu Ogawa, Junko Takiguchi, Manami Shimizu, et al.
The Tohoku Journal of Experimental Medicine|February 10, 2011
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, decreases systolic blood pressure in Japanese hypertensive patients with type 2 diabetesSusumu Ogawa, Mikihito Ishiki, Kazuhiro Nako, et al.
Clinical and Experimental Nephrology|March 24, 2017
The relationship between the renal reabsorption of cysteine and the lowered urinary pH in diabeticsSusumu Ogawa, Junko Takiguchi, Manami Shimizu, et al.
BMJ Open|April 17, 2012
Effects of the Great East Japan Earthquake and huge tsunami on glycaemic control and blood pressure in patients with diabetes mellitusSusumu Ogawa, Mikihito Ishiki, Kazuhiro Nako, et al.
The Tohoku Journal of Experimental Medicine|September 27, 2013
Eicosapentaenoic acid improves glycemic control in elderly bedridden patients with type 2 diabetesSusumu Ogawa, Takaaki Abe, Kazuhiro Nako, et al.
Diabetes Research and Clinical Practice|March 31, 2009
Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodiesTsuneo Ishizuka, Susumu Ogawa, Takefumi Mori, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 9, 2013
A decline in glomerular filtration rate rather than renal arterial stenotic lesions, per se, predicts cardiovascular-renal events in type 2 diabetic patientsSusumu Ogawa, Kazuhiro Nako, Masashi Okamura, et al.
American Journal of Hypertension|June 19, 2013
Identification of the stages of diabetic nephropathy at which angiotensin II receptor blockers most effectively suppress albuminuriaSusumu Ogawa, Masato Matsushima, Takefumi Mori, et al.
Diabetology International|January 21, 2022
Electrolyzed hydrogen-rich water for oxidative stress suppression and improvement of insulin resistance: a multicenter prospective double-blind randomized control trialSusumu Ogawa, Yusuke Ohsaki, Manami Shimizu, et al.
Biomarker Insights|August 5, 2009
Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic NephropathySusumu Ogawa, Hiroyuki Kobori, Naro Ohashi, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Tohoku Journal of Experimental Medicine|May 31, 2016
The Reduction in Urinary Glutamate Excretion Is Responsible for Lowering Urinary pH in Pink Urine SyndromeSusumu Ogawa, Junko Takiguchi, Manami Shimizu, et al.
The Tohoku Journal of Experimental Medicine|February 10, 2011
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, decreases systolic blood pressure in Japanese hypertensive patients with type 2 diabetesSusumu Ogawa, Mikihito Ishiki, Kazuhiro Nako, et al.
Clinical and Experimental Nephrology|March 24, 2017
The relationship between the renal reabsorption of cysteine and the lowered urinary pH in diabeticsSusumu Ogawa, Junko Takiguchi, Manami Shimizu, et al.
BMJ Open|April 17, 2012
Effects of the Great East Japan Earthquake and huge tsunami on glycaemic control and blood pressure in patients with diabetes mellitusSusumu Ogawa, Mikihito Ishiki, Kazuhiro Nako, et al.
The Tohoku Journal of Experimental Medicine|September 27, 2013
Eicosapentaenoic acid improves glycemic control in elderly bedridden patients with type 2 diabetesSusumu Ogawa, Takaaki Abe, Kazuhiro Nako, et al.
Diabetes Research and Clinical Practice|March 31, 2009
Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodiesTsuneo Ishizuka, Susumu Ogawa, Takefumi Mori, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 9, 2013
A decline in glomerular filtration rate rather than renal arterial stenotic lesions, per se, predicts cardiovascular-renal events in type 2 diabetic patientsSusumu Ogawa, Kazuhiro Nako, Masashi Okamura, et al.
American Journal of Hypertension|June 19, 2013
Identification of the stages of diabetic nephropathy at which angiotensin II receptor blockers most effectively suppress albuminuriaSusumu Ogawa, Masato Matsushima, Takefumi Mori, et al.
Diabetology International|January 21, 2022
Electrolyzed hydrogen-rich water for oxidative stress suppression and improvement of insulin resistance: a multicenter prospective double-blind randomized control trialSusumu Ogawa, Yusuke Ohsaki, Manami Shimizu, et al.
Biomarker Insights|August 5, 2009
Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic NephropathySusumu Ogawa, Hiroyuki Kobori, Naro Ohashi, et al.
Pageof 3